Patent · US Active

Crystal form of five-membered n heterocyclic compound, and application thereof

US12384745B2 · kind B2 · utility

0Cited by

1References

16Claims

0Family size

Assignee

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · CN

Inventors

Pujun Wang · Lianyungang, CN
Meng Guo · Shanghai, CN
Mingtong Hu · Lianyungang, CN
Jie Wu · Freeport, US
Wangwei Ao · Lianyungang, CN
Yinsheng Zhang · Lianyungang, CN

Key dates

Filing date	Sep 28, 2020
Grant date	Aug 12, 2025
Priority date	—
Expiry date	Dec 20, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are a crystalline form of a five-membered N heterocyclic compound, particularly, a crystalline form of a compound as represented by formula I, and an application of the crystalline form in preparation of a medication for preventing or treating a disease benefiting from inhibition of capsid protein assembly.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.